Bisphosphonate effectiveness in patients with cirrhosis: An emulated clinical trial
Alimentary Pharmacology & Therapeutics · 2024
DOI: 10.1111/apt.18127 ↗At a glance
Journal article in Alimentary Pharmacology & Therapeutics, 2024. Written by Elliot B Tapper and 4 co-authors. Institution: Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA. Major MEDLINE topics: Liver Cirrhosis, Diphosphonates, Bone Density Conservation Agents, Osteoporosis. Cited 8 times so far (Crossref); 25 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIDDK NIH HHS.
Abstract (original language)
Background
Falls and fractures are common and morbid for patients with cirrhosis. Bisphosphonates are recommended for the prevention of fractures for people with osteoporosis cirrhosis; however, data supporting effectiveness in cirrhosis are lacking.
Aim
We sought to emulate a clinical trial of bisphosphonates in cirrhosis.
Methods
We used national Medicare data (2008–2020) to examine the 5‐year risk of fractures in patients who did or did not receive bisphosphonates with a new‐user design among people diagnosed with cirrhosis and osteoporosis. We balanced treated and untreated with inverse probability of treatment weighting, evaluated intention‐to‐treat and as‐treated effects, and examined both control exposures (statin use) and outcomes (decompensation) to test causal relationships.
Results
There were 253 and 20,888 new users and non‐users of bisphosphonates, respectively. The median age was 74 years. The most common bisphosphonate used was alendronate (73.6%). Bisphosphonates significantly reduced fractures overall (27.5% vs. 33.0%, p = 0.0004) in the intention‐to‐treat analysis, particularly for people
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.
- Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, University of Aarhus, Aarhus, Denmark.
ORCID profiles: Peter Jepsen, Neehar D Parikh
Funding
- NIDDK NIH HHS
Cite
APA
Tapper, E. B., Martinez, B., Jepsen, P., Chen, X., & Parikh, N. D. (2024). Bisphosphonate effectiveness in patients with cirrhosis: An emulated clinical trial. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18127
Vancouver
Tapper EB, Martinez B, Jepsen P, Chen X, Parikh ND. Bisphosphonate effectiveness in patients with cirrhosis: An emulated clinical trial. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.18127
BibTeX
@article{Tapper2024,
author = {Tapper, Elliot B and Martinez, Beanna and Jepsen, Peter and Chen, Xi and Parikh, Neehar D},
title = {Bisphosphonate effectiveness in patients with cirrhosis: An emulated clinical trial},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
doi = {10.1111/apt.18127}
}
EUVIMED